People with polyendocrine metabolic ovarian syndrome (PMOS) should have their condition diagnosed sooner and be offered an annual review to monitor symptoms, treatment and long-term health risks, ...

Despite affecting millions of women in the UK, PMOS is still under-diagnosed and inconsistently managed, say experts.

Hormone condition PMOS affects about one in eight women, but often goes undiagnosed for years despite increasing risk of ...

Under new draft guidelines, women with the common endocrine condition will be offered a yearly review to help manage their ...

Read more about the National Institute for Health and Care Excellence’s new guidance on polyendocrine metabolic ovarian ...

Patients with PMOS should have their condition diagnosed sooner and be offered an annual review, NICE has said.

Women with polyendocrine metabolic ovarian syndrome (PMOS) in the UK should get diagnosed sooner and be offered an annual review of their condition, according to new guidance from NICE. Draft guidance ...

Yet, minor irregularities are easily dismissed as temporary inconveniences. According to The Guardian, medical experts are ...

Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...

Millions of women with ‘common but overlooked’ condition offered annual review - Women with polyendocrine metabolic ovarian ...

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition ...

Polyendocrine metabolic ovarian syndrome (formerly known as PCOS) and infertility are linked, but it’s still possible to get ...